Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Clinical trial NCT03282591 · COMPLETED
Trial details
- NCT number
- NCT03282591
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-03
- Primary completion
- 2018-08-15
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.